What is the importance of infliximab and cyclosporine in the treatment of corticosteroid-refractory severe ulcerative colitis?
The Turkish Journal of Gastroenterology · 2012
DOI: 10.4318/tjg.2012.0616 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Turkish Journal of Gastroenterology, 2012. Verfasst von Göksel Bengi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Dokuz Eylül University, School of Medicine, İzmir, Turkey. goksel.bengi@deu.edu.tr. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Dokuz Eylül University, School of Medicine, İzmir, Turkey. goksel.bengi@deu.edu.tr
Zitieren
APA
Bengi, G., & Akpinar, H. (2012). What is the importance of infliximab and cyclosporine in the treatment of corticosteroid-refractory severe ulcerative colitis?. The Turkish Journal of Gastroenterology. https://doi.org/10.4318/tjg.2012.0616
Vancouver
Bengi G, Akpinar H. What is the importance of infliximab and cyclosporine in the treatment of corticosteroid-refractory severe ulcerative colitis?. The Turkish Journal of Gastroenterology. 2012. doi:10.4318/tjg.2012.0616
BibTeX
@article{Bengi2012,
author = {Bengi, Göksel and Akpinar, Hale},
title = {What is the importance of infliximab and cyclosporine in the treatment of corticosteroid-refractory severe ulcerative colitis?},
journal = {The Turkish Journal of Gastroenterology},
year = {2012},
doi = {10.4318/tjg.2012.0616}
}
EUVIMED